The advent of numerous PDK4 client substrates offers the possibility that a significant biological activity remains under investigation and may be highly relevant to future studies, particularly in regard to the ability of PDK4 to suppress tumor formation rather than enhance it. The gene discussed is PDK4; the disease is neoplasm.